|
Although pneumococcal vaccines have been used for older children and adults for many years, a new form of pneumococcal vaccine is now recommended by the American Academy of Pediatrics (AAP) for all children younger than age 2. This vaccine is called pneumococcal conjugate vaccine (PCV7).
The AAP also recommends that PCV7 be given to all children ages 24 to 59 months of age who are at very high risk for developing pneumococcal infections. This includes children who have weakened immune (infection fighting) systems, such as those with sickle cell disease and HIV infection (human immunodeficiency virus).
|